Literature DB >> 2505543

The septum pellucidum: normal and abnormal.

M Sarwar1.   

Abstract

The common embryologic origin of the septum pellucidum, of the corpus callosum, and of the limbic system explains the anatomic basis of a varying degree of concurrent involvement of these structures in disease processes, both developmental and acquired. Developmental absence of the septum pellucidum portends a more generalized dysplasia that encompasses the corpus callosum and the limbic system. When considered in this context, it is easy to understand the limbic system dysfunction that is engendered by this anomaly. It is rare for an acquired lesion to involve the septum pellucidum per se because of its small size. However, it is common for it to be secondarily involved in almost all types of acquired disease processes. With the exquisite anatomic morphology that MR now provides, one must carefully assess involvement of the septum pellucidum, of the corpus callosum, and of the limbic system in disease processes that occur in the vicinity of these structures, so that more incisive clinical insight into the functions that are subserved by these structures can be obtained.

Entities:  

Mesh:

Year:  1989        PMID: 2505543      PMCID: PMC8335275     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  40 in total

1.  Amygdala-hippocampal shape differences in schizophrenia: the application of 3D shape models to volumetric MR data.

Authors:  Martha E Shenton; Guido Gerig; Robert W McCarley; Gábor Székely; Ron Kikinis
Journal:  Psychiatry Res       Date:  2002-08-20       Impact factor: 3.222

2.  Cavum septum pellucidum in monozygotic twins discordant for combat exposure: relationship to posttraumatic stress disorder.

Authors:  Flavia S May; Q Cece Chen; Mark W Gilbertson; Martha E Shenton; Roger K Pitman
Journal:  Biol Psychiatry       Date:  2004-03-15       Impact factor: 13.382

Review 3.  Neurocriminology: implications for the punishment, prediction and prevention of criminal behaviour.

Authors:  Andrea L Glenn; Adrian Raine
Journal:  Nat Rev Neurosci       Date:  2013-12-11       Impact factor: 34.870

4.  The relationship between large cavum septum pellucidum and antisocial behavior, callous-unemotional traits and psychopathy in adolescents.

Authors:  Stuart F White; Sarah Brislin; Stephen Sinclair; Katherine A Fowler; Kayla Pope; R James R Blair
Journal:  J Child Psychol Psychiatry       Date:  2012-08-31       Impact factor: 8.982

Review 5.  Twin studies of posttraumatic stress disorder: differentiating vulnerability factors from sequelae.

Authors:  William S Kremen; Karestan C Koenen; Niloofar Afari; Michael J Lyons
Journal:  Neuropharmacology       Date:  2011-03-31       Impact factor: 5.250

6.  Qualitative MRI findings in adults with 22q11 deletion syndrome and schizophrenia.

Authors:  E W Chow; D J Mikulis; R B Zipursky; L E Scutt; R Weksberg; A S Bassett
Journal:  Biol Psychiatry       Date:  1999-11-15       Impact factor: 13.382

7.  The relationship between cavum septum pellucidum and psychopathic traits in a large forensic sample.

Authors:  Dana Crooks; Nathaniel E Anderson; Matthew Widdows; Nia Petseva; Michael Koenigs; Charles Pluto; Kent A Kiehl
Journal:  Neuropsychologia       Date:  2018-03-12       Impact factor: 3.139

8.  Giant cyst of the cavum septi pellucidi and cavum Vergae with posterior cranial fossa extension: case report.

Authors:  M A Bayar; C Gökçek; A Gökçek; N Edebali; Z Buharali
Journal:  Neuroradiology       Date:  1996-05       Impact factor: 2.804

9.  Endoscope-assisted microsurgery for tumors of the septum pellucidum: surgical considerations and benefits of the method in the treatment of four serial cases.

Authors:  M Fratzoglou; A R Leite dos Santos; I Gawish; A Perneczky
Journal:  Neurosurg Rev       Date:  2004-05-12       Impact factor: 3.042

10.  Three-dimensional morphometric analysis of brain shape in nonsyndromic orofacial clefting.

Authors:  Seth M Weinberg; Nancy C Andreasen; Peg Nopoulos
Journal:  J Anat       Date:  2009-06       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.